Elisa Zavattaro

31PUBLICATIONS
178CO-AUTHORS
Solid tumoursPharmaceutical delivery technologiesTransport properties and non-equilibrium processesDisease surveillanceInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 01, 2026
A single-center prospective observational study evaluating the efficacy and safety of tirbanibulin 1% in actinic keratoses in immunosuppressed patients: the ESTIMATE study.

|Mar 28, 2026
Magistral Galenic Preparations in Modern Dermatology: Our Top 10 Picks for Bridging Therapeutic Gaps.

Edoardo Cammarata, Elia Esposto, Laura Cristina Gironi

|Mar 14, 2026
Aquaporins as Regulators of Cutaneous Malignancies: A Comprehensive Review.

Lara Camillo, Elisa Zavattaro, Paola Savoia

|Dec 31, 2025
The Dermatology Fast Track as a Model for Integrated Care Pathways Between Emergency Medicine and Outpatient Specialty Services.

Edoardo Cammarata, Chiara Airoldi, Elisa Zavattaro

|Nov 26, 2025
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

A Carugno, G Nazzaro, L Argnani

|Aug 22, 2025
Benzyl benzoate and ivermectin are more effective than permethrin for treating scabies: A multicentre study.

Edoardo Cammarata, Stefania Marchianò, Elia Esposto

Pageof 6